Engineering catalytically defective forms of HIV protease to modulate its activity

Adv Exp Med Biol. 1998:436:31-9. doi: 10.1007/978-1-4615-5373-1_4.
No abstract available

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Anti-HIV Agents
  • Catalysis
  • Dimerization
  • HIV Protease / genetics*
  • HIV Protease / metabolism*
  • HIV-1 / enzymology*
  • HIV-1 / physiology
  • Humans
  • Protein Engineering
  • Virion

Substances

  • Anti-HIV Agents
  • HIV Protease